Centro di Riferimento Oncologico

Centro di Riferimento Oncologico

Item
http://www.wikidata.org/entity/Q30281668
Bone Density and Bone Loss in Postmenopausal Women With Breast Cancer Receiving Treatment in Clinical Trial IBCSG-1-98Study on Leiomyosarcoma, Liposarcomas and Synovial Sarcoma With TrabectedinHormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast CancerRT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's DiseaseVaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With SurgeryMEN-10755 in Treating Adults With Recurrent or Refractory Solid TumorsCombination Chemotherapy in Treating Patients With HIV-Related Non-Hodgkin's LymphomaA Study of Brigatinib in Participants With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non-Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or CeritinibAn Efficacy Study Comparing Brigatinib Versus Alectinib in Advanced Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer Participants Who Have Progressed on CrizotinibA Phase 1 Drug-Drug Interaction Study Between Brigatinib and the CYP3A Substrate, Midazolam, in Patients With ALK-Positive or ROS1-Positive Solid TumorsCAPTEM or FOLFIRI as SEcond-line Therapy in NEuroendocrine CArcinomasA Study of Cetrelimab (JNJ-63723283), a Programmed Cell Death Receptor-1 (PD-1) Inhibitor, Administered in Combination With Apalutamide in Participants With Metastatic Castration-Resistant Prostate CancerClinical Trial of Lurbinectedin (PM01183)/Doxorubicin (DOX) Versus Cyclophosphamide (CTX), Doxorubicin (DOX) and Vincristine (VCR) (CAV) or Topotecan as Treatment in Patients With Small-Cell Lung Cancer
P6153
Q37378489-CDD76BE2-1041-48E0-B7F6-0284CDC88ED5Q38524375-32BF3DF8-5260-4B7C-971A-14179E32D502Q39189139-B1E21436-6C15-40CC-BFCC-9A703D80E8C6Q39189157-1BA8D1E0-2388-4512-A8F7-D4F7339748A4Q40562067-00266DAF-434C-4FC8-AFB0-07A8A73F7A9CQ40562067-11336C46-1E9A-48CE-AE0B-99081547FCE7Q40562067-1AC1F469-3936-4AB4-9852-6F5CA4EBE828Q40562067-5C079BFE-2E63-41F6-AB58-472716340154Q40562067-DAE4680F-E4F3-453A-A5A3-60E4793520DCQ42133616-20329648-69B3-4CA8-8976-9C59D3A27733Q42133616-66AA20FF-7BB0-4C2B-89D5-E143F4A163C1Q42410152-96DFDF5D-092F-408B-BE30-DC7805D6E18AQ42410152-DC88BDF8-9E85-4698-BD68-3F989597FEA1Q42410152-E3AA70A8-8BE0-494B-94DD-1FC2D239F540Q42660720-434EEACC-D408-43DC-90B9-448C2A12D881Q42675621-3BDD5616-3D25-40AE-B575-A97C72CED598Q42703041-BC8EF672-D4A0-4754-B913-E68F122B5276Q42772888-3980429B-47CD-48BE-A822-8E98F909D937Q42807505-39E00139-A770-4BE1-80BF-C2C4FA894302Q42852738-BDD9B789-0659-4946-A5AE-32F6DBC210B8Q43108192-9F491576-9878-4A48-9FE6-B8F00BC2D8F6Q43176173-156AB2BF-A5EB-49AE-B5CA-C73B44B6BED1Q43258178-7220D862-BB93-4DE1-8858-58E0A91A75F0Q49866420-71225640-0008-426E-8B66-365A5EB1FB89Q53424455-25C31CFB-6880-4116-B5A1-D5BCD3BFC088Q53424455-91CE0FC2-3B7C-4344-8E19-F2402D7121FAQ54991103-94A8ED19-7E07-4E85-850C-98BD1951410DQ55414251-7AD3C431-C283-4B1B-8045-4D8915D71713Q55437633-83BF552D-436E-431D-9675-0B58E5199693Q55459210-55EC6A65-BA95-4194-B06F-3F28B09E143CQ56381111-29BA6EB6-F500-4B22-BA5B-117989653541Q56417107-617084D4-9E3E-4F75-926B-70B70E7B066DQ56915518-5FAB173E-5DE9-47F0-8C12-67C95218B9B2Q57023125-19AB5666-6DC9-4B06-8231-4D2928DE9C94Q57023125-C7ED4C8A-CF4C-4445-99FA-8EC69B4A239DQ57023125-C86F00F8-BE4B-4510-ADE2-03A19B651466Q57042707-85DD2BD6-541E-455A-862C-65D3E510DAD5Q57064518-D974920B-834D-48F8-81AA-60762FE6CE9DQ57144355-C5B3B444-F6DB-41A3-9B1F-ECC67A2BEA8FQ57453177-F98438E6-8ADE-4A5A-80CE-0B50575A98B3
P108

Centro di Riferimento Oncologico

Item
http://www.wikidata.org/entity/Q30281668
description
healthcare organization in Aviano, Italy
@en
name
Centro di Riferimento Oncologico
@en
type
label
Centro di Riferimento Oncologico
@en
altLabel
CRO
@en
prefLabel
Centro di Riferimento Oncologico
@en
P131
P17
P213
P2427
P31
P3500
P571
P625
P6782
P749
P856
P131
P17
P213
P2427
P31
P3500
P571
P625
P6782
P749
P856